119 results
10-Q
ferut5wnyvh9
14 May 18
Quarterly report
7:01am
8-K
EX-99.1
d2c118uzm
3 Jan 19
Unum Therapeutics Announces Transition of Chief Financial Officer
7:23am
8-K
EX-99.1
cido7tmer0ul4uk
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-99.1
x1b2qn0v
2 Jul 19
Unum Therapeutics Announces Regulatory Update from Phase 1 Trial with ACTR087
4:40pm
8-K
EX-99.2
ryu1i4
13 Aug 18
Unum Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
4:32pm
8-K
EX-99.1
mqv3rq jtel2rmtyyj2
29 Jan 20
Other Events
7:13am
8-K/A
EX-99.1
u57hgh gl
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-99.1
041hvo6 mmg
29 Jul 19
Unum Therapeutics Announces New Appointments to its Board of Directors
7:24am
8-K
EX-99.2
c4sl5z0 scg1dvqd
3 Jan 19
Unum Therapeutics Announces Transition of Chief Financial Officer
7:23am
8-K
EX-99.1
4qlj17bazuzsbatqh
26 Oct 20
Cogent Biosciences Appoints
7:13am
8-K
EX-99.1
nbzlpv 1nitbx4sp
3 Dec 18
Unum Therapeutics Presents Preliminary Results from Ongoing Phase 1 StudyATTCK-17-01 at the 2018 ASH Annual Meeting
7:50am